Non-vitamin K Antagonist Oral Anticoagulant, Warfarin, and ABC Pathway Adherence on Hierarchical Outcomes: Win Ratio Analysis of the COOL-AF Registry

Sukrit Treewaree; Professor Gregory Lip; Rungroj Krittayaphong

doi:10.1055/s-0043-1772773

Back

Non-vitamin K Antagonist Oral Anticoagulant, Warfarin, and ABC Pathway Adherence on Hierarchical Outcomes: Win Ratio Analysis of the COOL-AF Registry

Article 2023 en

Abstract

1 min read

This Win Ratio analysis demonstrates the significant benefits of NOACs over warfarin and ABC pathway adherence over nonadherence in reducing the composite outcome in patients with AF.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2019

P4793Comparing the effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in the elderly Asian patients with atrial fibrillation

Tze‐Fan Chao, Jo‐Nan Liao, Professor Gregory Lip, S A Chen

Article2019

Non–Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Supranormal Renal Function

Seil Oh, Professor Gregory Lip, So-Ryoung Lee, Eue-Keun Choi, Kyungdo Han, Jin‐Hyung Jung, Myung‐Jin Cha

Article2019

P4780Effectiveness and safety of non-vitamin k antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease

Inki Moon, S R Lee, Eunsuk Choi, E J Lee, Jin‐Hyung Jung, Kyungdo Han, M J, Seil Oh, Professor Gregory Lip

Article2022

Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation

J Farinha, Ian Jones, Professor Gregory Lip

Article2019

Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage

Peter Brønnum Nielsen, Flemming Skjøth, Mette Søgaard, Jette Nordstrøm Kjældgaard, Professor Gregory Lip, Torben Bjerregaard Larsen